AstraZeneca推出新的高血压药物,旨在增加收入并达到800亿美元的目标。 AstraZeneca launches new hypertension drug, aiming to boost revenue and reach an $80 billion goal.

AstraZeneca是一家主要的制药公司,在推出一种新的高血压药物后,朝着其800亿美元的目标迈出了重要一步。 AstraZeneca, a leading pharmaceutical company, has taken a significant step toward its $80 billion goal with the launch of a new hypertension drug. 这种创新药物预计将增加公司的收入,并通过提供新的高血压治疗来巩固其在制药市场的地位。 This innovative medication is expected to boost the company's revenue and solidify its position in the pharmaceutical market by offering a new treatment for high blood pressure.